RO7268489 clinical trials

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

This study looks at a new medicine called RO7268489 for people with progressive multiple sclerosis (MS) who are already taking ocrelizumab. We want to see if adding RO7268489 helps, and if it's safe. Some people might also get the new medicine after the main part of the study.